Announcement of adjustment of an item in the plan of 2018 cash capital increase

Date of the board of directors resolution for the change:2024/08/02 Effective registration date of the original plan:2019/03/25 Resolution date of additional issuance: Not applicable Major change Reason for the change: (1)OBI-866, as one of the items in the plan of 2018 cash capital increase, is an active immunotherapeutic cancer vaccine targeting SSEA-4, whose study population […]